Medical history
Ask how medication use, substance use, heart history, psychiatric history, and other conditions are reviewed before travel.
Cancún & Riviera Maya
Clinic Evaluation Checklist
An actionable, non-commercial set of questions for comparing ibogaine providers in Cancún, Playa del Carmen, Tulum, Cozumel, and linked Baja facilities.
Start with documentation
Marketing language is not evidence of clinical readiness.
Use this checklist to ask for clear answers before travel. It does not endorse individual centers or infer competence from appearance, testimonials, location, or promises.
A provider should be able to explain screening, monitoring, emergency response, consent, adverse-event reporting, and aftercare without substituting vague assurances for records or protocols.
- Ask what is checked before arrival and what findings would postpone or rule out treatment.
- Ask who is present during dosing, who makes medical decisions, and how credentials can be verified.
- Ask what happens if a serious complication requires care beyond the facility.
Evaluation categories
Before travel: screen the process, not the promise.
Begin with the regional context in the Cancún ibogaine overview, then compare what a prospective provider actually documents. Questions about cost should be separate from medical suitability; an independent look at ibogaine treatment costs in Mexico can help keep financial claims from standing in for safety information.
ECG and labs
Ask when an ECG and lab work are required, who reviews results, and what happens when results raise concern.
Clear exclusions
Ask for the circumstances in which the provider would decline, delay, or refer a prospective patient elsewhere.
What to verify on site
Make the operational questions concrete.
Ibogaine has been associated with serious cardiac risks, including arrhythmias. The U.S. Food and Drug Administration notes that unapproved drugs have not been reviewed for safety or effectiveness, while the ibogaine reference overview describes its history and reported safety concerns. Those facts do not establish what any individual provider can safely manage.
Medical staffing and credentials
Ask which licensed professionals are physically present during screening, dosing, overnight observation, and a medical emergency. Ask how their credentials, roles, and scope of responsibility can be verified. A name on a website is not an answer to who is present at the relevant time.
Ask who interprets ECG and lab findings, who reviews medication interactions, and who has authority to stop the process when risk information changes.
Monitoring, medication, and emergency readiness
Ask what vital-sign and cardiac monitoring is available, how often it is used, what emergency medications and oxygen are on site, and how staff practice for an acute event. Ask to have the transfer or evacuation plan explained in practical terms: destination, transport, responsibility, and what information travels with the patient.
The American Heart Association describes cardiac monitoring as a way to observe heart rhythm in clinical settings; see its overview of arrhythmias for context on why rhythm-related questions are material.
Consent, incident reporting, and documentation
Ask for the consent process before travel. It should address known and unresolved risks, alternatives, uncertainty, medication changes, and circumstances in which treatment may not proceed. Ask how adverse events are documented, who is notified, and whether a patient can receive relevant records after discharge.
Do not treat a waiver, a reassuring phrase, or a testimonial as a substitute for a clear conversation about risk and documented decision-making.
Continuity and harm reduction
Look beyond the stay itself.
Ask what preparation is expected before travel, what support is available after discharge, and how the provider coordinates—with permission—with a person’s established clinician or support network at home. A directory such as where to find ibogaine may help identify locations, but a listing does not answer these continuity questions.
Ask whether a plan includes medication reconciliation, relapse and overdose-risk discussion, travel timing, follow-up expectations, and a way to obtain records. People comparing programs in Canada can also contrast regional questions through Canadian ibogaine options, while service descriptions should be weighed against the site’s scope of independent resources.
“If the answer cannot be made specific before travel, treat that uncertainty as part of the decision.”
Red flags and comparison
Be cautious with answers that stay vague.
Red flags include pressure to commit quickly, refusal to discuss screening exclusions, unclear staffing coverage, no intelligible emergency-transfer plan, or assurances that minimize medication and cardiac concerns. The Mexico treatment clinic comparison may help frame provider questions, but it should not be read as an endorsement.
For families weighing specialized circumstances, military-focused ibogaine considerations may surface additional continuity questions. For people seeking a broad directory lens, ibogaine detox center listings likewise do not replace direct verification. Regulation, licensure, and emergency systems can vary across regions, so keep the Mexico regulatory snapshot alongside the checklist.
Keep the record
Use the questions before any travel commitment.
Bring answers together with the regional safety guide and discuss health concerns with an appropriately qualified clinician.